Home › NDC Lookup › RxCUI directory › RxCUI 2472783

Relugolix 120 MG Oral Tablet — RxCUI 2472783

RxNorm drug concept · Semantic clinical drug
RxCUI 2472783 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2472783
Official nameRelugolix 120 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)6,636 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Relugolix: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Orgovyx works by blocking signals in your brain that normally tell your body to make testosterone. Prostate cancer cells need testosterone to grow, so by driving testosterone down...
  • What is Orgovyx actually doing to treat my prostate cancer?
  • Good news — you can take it with or without food, whichever works best for your routine. The most important thing is to take it at roughly the same time each day. Just remember to...
  • Can I take my Orgovyx tablet with breakfast, or does it have to be on an empty stomach?
📖 Read our full Relugolix guide →

🕸️ Concept Web — How Relugolix 120 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Relugolix 120 MG Oral Tablet RxCUI 2472783

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Relugolix 2472778
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Orgovyx 2472784
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Relugolix Oral Tablet 2472782
    • Relugolix Oral Product 2472780
    • Relugolix Pill 2472781
    • Relugolix Oral Tablet [Orgovyx] 2472786
    • Orgovyx Oral Product 2472787
    • Orgovyx Pill 2472788
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Relugolix 120 MG SCDC · 2472779
  • Relugolix Oral Tablet SCDF · 2472782
  • Relugolix Oral Product SCDG · 2472780
  • Relugolix Pill SCDG · 2472781

Brand-Name Concepts

  • Relugolix 120 MG Oral Tablet [Orgovyx] SBD · 2472789
  • Relugolix 120 MG [Orgovyx] SBDC · 2472785
  • Relugolix Oral Tablet [Orgovyx] SBDF · 2472786
  • Orgovyx Oral Product SBDG · 2472787
  • Orgovyx Pill SBDG · 2472788
  • Orgovyx BN · 2472784

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 2472783 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72974-0120-01 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01) Orgovyx Sumitomo Pharma America, Inc. 2020-12-18
72974-0120-95 16 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95) Orgovyx Sumitomo Pharma America, Inc. 2023-01-27
72974-0120-97 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97) Orgovyx Sumitomo Pharma America, Inc. 2021-10-21
Observed labelers: Sumitomo Pharma America, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.